港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

MIRXES-B

45.600

-0.580-1.26%

成交量：18.01万

成交额：829.52万

市值：126.01亿

市盈率：-59.30

高：47.000

开：47.000

低：45.020

收：46.180

52周最高：48.700

52周最低：27.050

股本：2.76亿

香港流通股本：2.76亿

量比：0.36

换手率：0.07%

股息：- -

股息率：- -

每股收益(LYR):-0.769

净资产收益率：--

总资产收益率：-51.53%

市净率：-7.74

市盈率(LYR):-59.30

市销率: 79.59

数据加载中...

总览公司新闻公告

觅瑞MIRXES-B于港交所主板成功上市，毕马威作为其申报会计师提供专业服务

港股综述｜恒瑞医药首日飙涨25%，Mirxes涨28%；阿里影业涨超8%，港股三大股指冲高回落

老虎资讯综合

MIRXES-B(02629)首挂收报30港元较招股价高28.76%

《新股》MIRXES-B(02629.HK)全日收30元高上市价28.8%

阿斯达克财经

新加坡生物科技公司觅瑞集团在港上市

【IPO追踪】股价一度飙37%！MIRXES上市首日表现强劲

港股午评：恒指涨0.58%科指涨0.61%！恒瑞医药涨超30%，MIRXES涨28%，哔哩哔哩涨5%，美团、网易、百度涨超1%

《新股》MIRXES-B(02629.HK)半日收29.8元高上市价27.9%

阿斯达克财经

祝贺！IVD企业敲钟上市，市值超80亿！

Mirxes觅瑞港股上市：募资净额8.8亿港元高榕创投是早期股东

刚刚，他靠一管血验癌IPO了

招银国际助力Mirxes Holding Company Limited首次成功公开发行并在香港联交所主板挂牌上市

前淘宝总裁收获一个IPO！Mirxes觅瑞登陆港交所开盘涨27%，市值82亿港元

《股市简讯》新加坡生物技术公司Mirxes香港“首秀”，盘初飙涨37%

MIRXES-B首挂上市股价现涨超30%

港股生物医药板块狂飙，新股恒瑞医药、MIRXES均涨超30%

《新股》MIRXES-B(02629.HK)首日开报29元高上市价24.5%

阿斯达克财经

异动解读 | MIRXES-B盘中大涨33%，港股IPO首日表现亮眼

异动解读 | 新股热潮持续，MIRXES-B上市首日大涨33.26%

【新股IPO】MIRXES-B(02629)首挂开报29港元较招股价高24.46%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/02629/news?page=3"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02629","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02629\",,,,,undefined,":{"symbol":"02629","market":"HK","secType":"STK","nameCN":"MIRXES-B","latestPrice":45.6,"timestamp":1756193913566,"preClose":46.18,"halted":0,"volume":180100,"delay":0,"floatShares":276342331,"shares":276342331,"eps":-0.76899,"marketStatus":"交易中","change":-0.58,"latestTime":"08-26 15:44:00","open":47,"high":47,"low":45.02,"amount":8295182,"amplitude":0.042876,"askPrice":45.76,"askSize":600,"bidPrice":45.54,"bidSize":1300,"shortable":0,"etf":0,"ttmEps":-0.76899,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1756195800000},"marketStatusCode":2,"adr":0,"listingDate":1747929600000,"exchange":"SEHK","adjPreClose":46.18,"openAndCloseTimeList":[[1756171800000,1756180800000],[1756184400000,1756195200000]],"volumeRatio":0.356354,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02629\",,,,,undefined,":{"symbol":"02629","floatShares":276342331,"roa":"-51.53%","roe":"--","lyrEps":-0.76899,"volumeRatio":0.356354,"shares":276342331,"dividePrice":0,"high":47,"amplitude":0.042876,"preClose":46.18,"low":45.02,"week52Low":27.05,"pbRate":"-7.74","psRate":"79.59","week52High":48.7,"institutionHeld":0,"latestPrice":45.6,"committee":0.368421,"eps":-0.76899,"divideRate":0,"volume":180100,"delay":0,"ttmEps":-0.76899,"open":47,"prevYearClose":23.3,"prevWeekClose":45.82,"prevMonthClose":30.55,"prevQuarterClose":34.5,"fiveDayClose":48.36,"twentyDayClose":31,"sixtyDayClose":28.75},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02629\",params:#limit:5,,,undefined,":[{"date":"2025-08-25","symbol":"02629","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756085400000,"name":null,"time":"","dateTimestamp":1756051200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02629\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02629\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02629\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02629","date":"2025-08-25","current":-16.849413,"percent":0.015625,"low":-17.63001,"twenty":-12.493638,"median":-11.382498,"eighty":-10.789519,"high":-10.373055,"avg":-11.989697,"sd":1.72626,"marketCap":12152035222},"quantilePoints":[{"date":"2025-05-30","current":-10.615633,"twenty":-10.820807,"median":-10.729406,"eighty":-10.614136,"marketCap":7683833445},{"date":"2025-06-06","current":-10.752673,"twenty":-10.811558,"median":-10.713624,"eighty":-10.576495,"marketCap":7789091437},{"date":"2025-06-13","current":-10.566273,"twenty":-10.761884,"median":-10.608146,"eighty":-10.555773,"marketCap":7657518947},{"date":"2025-06-20","current":-12.580768,"twenty":-10.923966,"median":-10.686264,"eighty":-10.56693,"marketCap":9117973591},{"date":"2025-06-27","current":-12.5082,"twenty":-12.340962,"median":-10.752673,"eighty":-10.581112,"marketCap":9065344595},{"date":"2025-07-04","current":-11.927039,"twenty":-12.355485,"median":-10.862871,"eighty":-10.586526,"marketCap":8644312625},{"date":"2025-07-11","current":-11.200931,"twenty":-12.261215,"median":-11.092147,"eighty":-10.600008,"marketCap":8118022663},{"date":"2025-07-18","current":-11.402889,"twenty":-12.217621,"median":-11.255392,"eighty":-10.612638,"marketCap":8262752403},{"date":"2025-07-25","current":-11.182791,"twenty":-12.077376,"median":-11.219171,"eighty":-10.651065,"marketCap":8104865414},{"date":"2025-08-01","current":-11.128301,"twenty":-11.949795,"median":-11.200931,"eighty":-10.68858,"marketCap":8065393667},{"date":"2025-08-08","current":-11.930929,"twenty":-11.952128,"median":-11.246394,"eighty":-10.71678,"marketCap":8646944075},{"date":"2025-08-15","current":-16.088166,"twenty":-12.119645,"median":-11.255421,"eighty":-10.743366,"marketCap":11636271059},{"date":"2025-08-22","current":-16.714103,"twenty":-12.435432,"median":-11.355275,"eighty":-10.780307,"marketCap":12057303029},{"date":"2025-08-25","current":-16.849413,"twenty":-12.493638,"median":-11.382498,"eighty":-10.789519,"marketCap":12152035222}],"updateTime":1756186957766},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02629\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2537380611","title":"觅瑞MIRXES-B于港交所主板成功上市，毕马威作为其申报会计师提供专业服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2537380611","media":"毕马威KPMG","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537380611?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 18:34","pubTimestamp":1747996440,"startTime":"0","endTime":"0","summary":"Mirxes Holding Company Limited于2025年5月23日在香港联合交易所主板完成首次公开发行并上市。毕马威作为觅瑞MIRXES-B上市的申报会计师参与该上市项目，提供专业服务。关于觅瑞MIRXES-B觅瑞MIRXES-B是一家总部位于新加坡的微小核糖核酸技术公司，致力于在亚洲关键市场提供疾病筛查诊断解决方案，提供用于癌症及其他疾病早期检测的基于血液的miRNA检测试剂盒。毕马威国际及其关联实体不提供任何客户服务。毕马威的名称和标识均属于毕马威国际的商标或注册商标。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2025-05-23/doc-inexpzxx0698661.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02629"],"gpt_icon":0},{"id":"1100549993","title":"港股综述｜恒瑞医药首日飙涨25%，Mirxes涨28%；阿里影业涨超8%，港股三大股指冲高回落","url":"https://stock-news.laohu8.com/highlight/detail?id=1100549993","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100549993?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 16:42","pubTimestamp":1747989772,"startTime":"0","endTime":"0","summary":"个股方面：“A+H药企龙头”恒瑞医药、“新加坡微小核糖核酸技术公司”Mirxes两只新股今日登陆港交所，分别收涨25.2%、28.76%。$中国卫生集团$今日复牌一度飙升超1.7倍，最终收涨110.71%，公司折让28.6%配股引入新投资者。阿里影业涨超8%，公司拟更名为大麦娱乐，$花旗$称IP商品潜力尚未完全释放。A股行情A股市场冲高回落，三大指数午后集体跳水。截至收盘，沪指跌0.94%报3348点，深证成指跌0.85%，创业板指跌1.18%。","market":"us","thumbnail":"https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"92258637d6ff1e9cb4f4844790de8572","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01060","HSI","02629","01276"],"gpt_icon":1},{"id":"2537618511","title":"MIRXES-B(02629)首挂收报30港元 较招股价高28.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537618511","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537618511?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 16:38","pubTimestamp":1747989480,"startTime":"0","endTime":"0","summary":"金吾财讯 | MIRXES-B(02629)首挂收报30港元，较招股价高28.76%，全日成交917.87万股，成交额2.75亿港元。不计手续费，每手100股，账面赚670港元。首挂开报29港元，亦为全日最低价，较招股价高24.46%，全日最高31.95港元。最新总市值82.9亿港元。","market":"other","thumbnail":"https://static.szfiu.com/news/20250107/NDRlODdhNTE5YzIwYjYxODZjOWYzMjY3ODIxMDI2ODM=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NDRlODdhNTE5YzIwYjYxODZjOWYzMjY3ODIxMDI2ODM=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1959225","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02629"],"gpt_icon":0},{"id":"2537188456","title":"《新股》MIRXES-B(02629.HK)全日收30元 高上市价28.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537188456","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537188456?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 16:15","pubTimestamp":1747988100,"startTime":"0","endTime":"0","summary":"MIRXES-B(02629.HK) 首日挂牌，开报29元，较上市价23.3元，高24.5%；最高/低分别见31.95/29元，全日收30元，较上市价23.3元，高28.8%，全日成交917.87万股，涉资2.74亿元。不计手续费，每手100股，账面赚670元。(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180815142909241_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180815142909241_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4ced5ebc15dd7b799c1c8ea5b39c4a94","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1442045/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02629"],"gpt_icon":0},{"id":"2537904786","title":"新加坡生物科技公司觅瑞集团在港上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2537904786","media":"新华财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537904786?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 14:37","pubTimestamp":1747982221,"startTime":"0","endTime":"0","summary":"新华财经香港5月23日电觅瑞集团（MIRXES-B，02629）23日在香港交易所主板上市，中金公司、建银国际为其联席保荐人。MIRXES-B每股发行价23.3港元，共发行4662万股股份，每手100股，所得款项净额约8.81亿港元。截至午市休盘，MIRXES-B上涨27.90%，报29.80港元，市值超82.35亿港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202505233413051755.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02629"],"gpt_icon":1},{"id":"2537902935","title":"【IPO追踪】股价一度飙37%！MIRXES上市首日表现强劲","url":"https://stock-news.laohu8.com/highlight/detail?id=2537902935","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537902935?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 14:24","pubTimestamp":1747981492,"startTime":"0","endTime":"0","summary":"5月23日，港股市场又迎来两只医药股上市，包括恒瑞医药（600276.SH，01276.HK）、MIRXES-B（02629.HK）。","market":"other","thumbnail":"https://images.finet.hk/photoLib/title/202505_1/1f92df6e-4d8f-4e00-a46c-27da160e6b69.PNG","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202505_1/1f92df6e-4d8f-4e00-a46c-27da160e6b69.PNG"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/683014b45a7712a46968709d","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["02629"],"gpt_icon":1},{"id":"2537190579","title":"港股午评：恒指涨0.58%科指涨0.61%！恒瑞医药涨超30%，MIRXES涨28%，哔哩哔哩涨5%，美团、网易、百度涨超1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537190579","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537190579?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 12:38","pubTimestamp":1747975099,"startTime":"0","endTime":"0","summary":"截至午间收盘，恒生指数涨0.58%，报23679.99点，恒生科技指数涨0.61%，国企指数涨0.75%。盘面上，科网股全线上涨，哔哩哔哩涨超5%，美团、网易、百度集团涨超1%；生物医药板块狂飙，新股恒瑞医药、MIRXES分别涨超30%、28%；影视股齐涨，阿里影业涨超11%。生物医药板块狂飙，新股恒瑞医药、MIRXES分别涨超30%、27%。近日，阿里大文娱集团宣布即日起更名为虎鲸文娱集团，旗下阿里影业拟更名为大麦娱乐。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523124040a6e9bb37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"92258637d6ff1e9cb4f4844790de8572","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523124040a6e9bb37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01060","02629","LU1969619763.USD","LU1328615791.USD","LU2488822045.USD","600276","BK0012","LU1064131003.USD","BK0060","BK0028","LU2328871848.SGD","BK0239","BK0188","LU0405327148.USD","BK0196","LU2148510915.USD","LU1064130708.USD","LU0405327494.USD","01276","BK0183"],"gpt_icon":0},{"id":"2537903070","title":"《新股》MIRXES-B(02629.HK)半日收29.8元 高上市价27.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537903070","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537903070?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 12:05","pubTimestamp":1747973100,"startTime":"0","endTime":"0","summary":"MIRXES-B(02629.HK) 首日挂牌，开报29元，较上市价23.3元，高24.5%。最高/低分别见31.95/29元，半日收29.8元，较上市价23.3元，高27.9%，半日成交714.95万股，涉资2.13亿元。(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190215132747632_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190215132747632_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4ced5ebc15dd7b799c1c8ea5b39c4a94","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1441970/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02629"],"gpt_icon":0},{"id":"2537900040","title":"祝贺！IVD企业敲钟上市，市值超80亿！","url":"https://stock-news.laohu8.com/highlight/detail?id=2537900040","media":"IVD资讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537900040?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 11:34","pubTimestamp":1747971278,"startTime":"0","endTime":"0","summary":"来源：IVD资讯综合高榕创投、觅瑞招股书5月23日，Mirxes觅瑞正式在香港联合交易所主板挂牌上市，每股发行价为23.30港元，开盘后市值超80亿港元！祝贺觅瑞成功敲钟上市，也给了这几年资本市场不振的IVD行业以信心和动力！公司的核心产品GASTROClear为一个由12种miRNA生物标志物组成的用于胃癌筛查的基于血液的miRNA检测组。全球大规模化的临床试验和药监认证，为Mirxes觅瑞未来在大范围内的产品推广和技术应用提供了有力保障。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523155157a6e9ee91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523155157a6e9ee91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02629"],"gpt_icon":1},{"id":"2537903834","title":"Mirxes觅瑞港股上市：募资净额8.8亿港元 高榕创投是早期股东","url":"https://stock-news.laohu8.com/highlight/detail?id=2537903834","media":"雷递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537903834?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 11:31","pubTimestamp":1747971101,"startTime":"0","endTime":"0","summary":"雷递网 乐天 5月23日Mirxes觅瑞今日在港交所上市，发行价为23.3港元。发行4662万股，募资总额为10.86亿港元，扣除发行上市费用2.06亿港元，募资净额为8.81亿港元。Mirxes觅瑞致力于使疾病筛查诊断解决方案在亚洲关键市场触手可及。2023年，Mirxes觅瑞在中国完成了9,472例受试者的注册临床试验，已向中国国家药品监督管理局提交了注册，有望在获批上市后为中国市场带来增长。高榕创投曾于2018年投资Mirxes觅瑞，是公司最早的机构股东，并长期陪伴公司发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523113735a6e9ac96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523113735a6e9ac96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HSCEI","HSTECH","02629"],"gpt_icon":1},{"id":"2537857970","title":"刚刚，他靠一管血验癌IPO了","url":"https://stock-news.laohu8.com/highlight/detail?id=2537857970","media":"投中网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537857970?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 10:37","pubTimestamp":1747967849,"startTime":"0","endTime":"0","summary":"一管血就能验癌的公司，成功上市了。按照弗若斯特沙利文的说法，作为一个由12种miRNA生物标志物组成的用于胃癌筛查的基于血液的miRNA检测组，GASTROClear为全球首款也是唯一一款获批准进行胃癌筛查的分子诊断IVD产品。一管血验癌，年入上亿元作为一家miRNA公司，Mirxes觅瑞目前拥有三种已商业化产品和六种处于临床前阶段的候选产品。其中，液体活检能通过检测血液及尿液等液体样本，寻找miRNA等癌症生物标志物，从而判断患者是否患癌。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505231038459762ae0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505231038459762ae0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02629"],"gpt_icon":1},{"id":"2537970274","title":"招银国际助力Mirxes Holding Company Limited首次成功公开发行并在香港联交所主板挂牌上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2537970274","media":"招银国际","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537970274?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 10:04","pubTimestamp":1747965896,"startTime":"0","endTime":"0","summary":"交易概述2025年5月23日，Mirxes Holding Company Limited成功于香港联合交易所主板挂牌上市。招银国际担任 Mirxes 在香港首次公开发行的联席账簿管理人及联席牵头经办人，助力Mirxes成功发行上市。Mirxes此次全球发行46,620,000股，发行价格为每股23.30港元，总募资金额约10.86亿港元。招银国际作为本次项目的联席账簿管理人及联席牵头经办人，充分发挥了在资本市场中的专业优势，为Mirxes的成功上市提供了全方位支持。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523105258a6e9a188&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523105258a6e9a188&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02629"],"gpt_icon":0},{"id":"2537972926","title":"前淘宝总裁收获一个IPO！Mirxes觅瑞登陆港交所开盘涨27%，市值82亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537972926","media":"地产k线","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537972926?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 09:45","pubTimestamp":1747964715,"startTime":"0","endTime":"0","summary":"乐居财经 吴文婷5月23日，觅瑞MIRXES-B在港交所挂牌上市，中金公司、建银国际联席保荐。其开盘报29.6港元，涨27%，总市值约81.8亿港元。据招股书，2022年-2024年，觅瑞实现收益分别为1775.9万美元、2418.5万美元、2028.27万美元；年内亏损分别为5620.27万美元、6956.93万美元、9221.47万美元。IPO前，前淘宝CEO孙彤宇全资拥有的Central Road持股22.03%，为觅瑞的第一大股东。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523094955a488f33b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"92258637d6ff1e9cb4f4844790de8572","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523094955a488f33b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02629","LU1051768304.USD","LU1044875133.USD","LU0359201885.HKD","LU0214875030.USD","LU0164865239.USD","BK1502","LU0396098781.USD","LU1993786604.SGD","LU0516423174.USD","LU0871576103.HKD","LU2097828557.USD","LU0011963245.USD","LU1282651121.HKD","LU0455707207.USD","IE00BMPRXR70.SGD","ALBmain","LU0589944569.HKD","HBBD.SI","LU0593848301.USD","LU1770034418.SGD","LU2039709279.SGD","SG9999014674.SGD","LU1303224171.USD","LU0348825331.USD","LU0106959298.USD","LU0650527681.SGD","BK1575","LU0588545904.SGD","SG9999000327.SGD","LU0164880469.USD","LU0531970944.HKD","LU0173614495.USD","BK1618","LU0577902611.USD","LU0359201612.USD","LU0648948544.HKD","LU1720051108.HKD","89988","LU0287142896.SGD","LU0898667661.SGD","LU1366334651.USD","LU0128522744.USD","LU0543330483.HKD","LU0572940350.SGD","LU0054450605.USD","LU0348783233.USD","LU1548497426.USD"],"gpt_icon":0},{"id":"2537971001","title":"《股市简讯》新加坡生物技术公司Mirxes香港“首秀”，盘初飙涨37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537971001","media":"路透中文","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537971001?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 09:38","pubTimestamp":1747964302,"startTime":"0","endTime":"0","summary":"《股市简讯》新加坡生物技术公司Mirxes香港“首秀”，盘初飙涨37%* 总部位于新加坡的微小核糖核酸技术公司--Mirxes2629.HK周五香港首日挂牌，盘初较招股价飙涨37%，触及31.95港元。* 该公司按招股价每股23.3港元发售4,662万股股份，集资10.86亿港元，上市市值64亿港元；香港公开发售和国际配售分别获25.5倍及0.98倍认购。* 香港股市恒生指数.HSI盘初跌0.1%，恒生香港上市生物科技指数.HSHKBIO涨1.8%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4ced5ebc15dd7b799c1c8ea5b39c4a94","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250523:nL4S3RV03Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02629","00656","BK1230"],"gpt_icon":1},{"id":"2537974427","title":"MIRXES-B首挂上市 股价现涨超30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537974427","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537974427?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 09:38","pubTimestamp":1747964280,"startTime":"0","endTime":"0","summary":"　　MIRXES-B首挂上市，公告显示，每股定价23.3港元，共发行4662万股股份，每手100股，所得款项净额约8.81亿港元。截至发稿，股价上涨30.47%，现报30.40港元，成交额1.20亿港元。　　公开资料显示，Mirxes成立于2014年，公司是一家总部位于新加坡的微小核糖核酸技术公司，致力于使疾病筛查诊断解决方案在亚洲关键市场触手可及。截至最后实际可行日期，集团拥有一种核心产品、两种其他商业化产品及六种处于临床前阶段的候选产品。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4ced5ebc15dd7b799c1c8ea5b39c4a94","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggipo/2025-05-23/doc-inexpeuk6281354.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02629"],"gpt_icon":0},{"id":"2537742369","title":"港股生物医药板块狂飙，新股恒瑞医药、MIRXES均涨超30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537742369","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537742369?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 09:35","pubTimestamp":1747964100,"startTime":"0","endTime":"0","summary":"5月23日消息，港股生物技术、药品股多股大涨，其中，今日正式上市的恒瑞医药和MIRXES分别涨超30%、36%。歌礼制药、博安生物、科伦博泰生物、凯莱英、信达生物等个股纷纷大涨。　　个股方面，恒瑞医药在公开发售阶段获454.85倍认购，国际配售阶段获17.09倍认购。据恒瑞医药披露的2024年年度报告，2024年公司实现营业收入279.85亿元，同比增长22.63%；归属于上市公司股东的净利润63.37亿元，同比增长47.28%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"92258637d6ff1e9cb4f4844790de8572","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/2025-05-23/doc-inexpeui1008253.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["161726","HSCEI","LU0405327148.USD","BK0188","07226","LU1328615791.USD","BK0196","BK0183","BK0060","BK0028","399441","LU1969619763.USD","01276","LU1064130708.USD","LU2148510915.USD","BK4614","BK0012","BK0239","LU1064131003.USD","LU0405327494.USD","LU2488822045.USD","HSTECH","YANG","600276","02629","LU2328871848.SGD"],"gpt_icon":0},{"id":"2537497485","title":"《新股》MIRXES-B(02629.HK)首日开报29元 高上市价24.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537497485","media":"阿斯达克财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537497485?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 09:35","pubTimestamp":1747964100,"startTime":"0","endTime":"0","summary":"MIRXES-B(02629.HK) 暗盘昨日收31.2元。高上市价33.9%。今日首日挂牌，开报29元，较上市价23.3元，高24.5%，开市时段成交374.14万股。(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20191017105308849_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20191017105308849_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4ced5ebc15dd7b799c1c8ea5b39c4a94","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1441906/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02629"],"gpt_icon":0},{"id":"1123728370","title":"异动解读 | MIRXES-B盘中大涨33%，港股IPO首日表现亮眼","url":"https://stock-news.laohu8.com/highlight/detail?id=1123728370","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123728370?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 09:32","pubTimestamp":1747963970,"startTime":"0","endTime":"0","summary":"新加坡生物科技公司MIRXES-B今日在香港联交所挂牌上市，股价表现亮眼。截至今日盘中，MIRXES-B股价大涨33.26%，引发市场广泛关注。公司此次IPO定价为每股23.3港元，募集资金净额约8.8亿港元。值得注意的是，MIRXES-B是全球首家也是唯一一家获得分子胃癌筛查IVD产品监管批准的公司，其核心产品GASTROClearTM已在新加坡成功商业化。分析人士指出，MIRXES-B的强劲表现反映了投资者对生物科技和医疗诊断领域的高度关注。此外，近期港股IPO普遍表现良好，也为MIRXES-B的上市营造了有利氛围。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4ced5ebc15dd7b799c1c8ea5b39c4a94","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02629"],"gpt_icon":0},{"id":"1109074535","title":"异动解读 | 新股热潮持续，MIRXES-B上市首日大涨33.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=1109074535","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109074535?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 09:32","pubTimestamp":1747963967,"startTime":"0","endTime":"0","summary":"今日盘中，新上市公司MIRXES-B股价大涨33.26%，延续了近期港股新股上市的强劲表现。MIRXES-B是一家总部位于新加坡的微小核糖核酸技术公司，专注于癌症及其他疾病的早期检测技术。MIRXES-B此次全球发售4662万股，每股发售价23.3港元，募集资金净额约8.8亿港元。然而值得注意的是，MIRXES-B目前仍处于亏损状态，2024年亏损达0.92亿美元。分析人士指出，MIRXES-B股价的强劲表现反映了市场对生物科技和早期疾病检测领域的高度关注。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4ced5ebc15dd7b799c1c8ea5b39c4a94","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02629"],"gpt_icon":0},{"id":"2537742309","title":"【新股IPO】MIRXES-B(02629)首挂开报29港元 较招股价高24.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537742309","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537742309?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 09:32","pubTimestamp":1747963930,"startTime":"0","endTime":"0","summary":"金吾财讯 | MIRXES-B(02629)首挂开报29港元，较招股价高24.46%，盘前成交307.37万股，成交额9027.65万港元，不计手续费，每手100股，账面赚570港元。据招股结果显示，每股定价23.3港元，集资10.86亿港元，净额约8.81亿港元。一手中签率95.00%，认购4手才可稳获一手。公开发售部分认购额为25.51倍，国际发售认购额为0.98倍。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250107/YzZkNGQ5YjgxMTczNjIxODI3MDA4NQ==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/YzZkNGQ5YjgxMTczNjIxODI3MDA4NQ==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4ced5ebc15dd7b799c1c8ea5b39c4a94","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1959178","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02629"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":88,"code":"91000000","status":"200"}]}}